# Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

> **NCT06953206** · — · NOT_YET_RECRUITING · sponsor: **Institut für Pharmakologie und Präventive Medizin** · enrollment: 500 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Replacement (TAVR)
- Aortic-Stenosis
- Aortic Insufficiency
- Degenerative Valve Disease

## Interventions

- **PROCEDURE:** Transcatheter aortic valve (S3UR) replacement (TAVR)

## Key facts

- **NCT ID:** NCT06953206
- **Lead sponsor:** Institut für Pharmakologie und Präventive Medizin
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2037-05-30
- **Final completion:** 2037-09-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953206, "Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06953206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*